Skip to content
10-Q

Quarterly Report

TRILLIUM THERAPEUTICS INC.

0001558370-21-015625

← back to feed
Filed
Nov 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Nov 10, 2021 105M sh
Capex Q3 2021 · Sep 30, 2021 $320K
Operating Cash Flow Q3 2021 · Sep 30, 2021 −$42.55M
Operating Cash Flow Q3 2021 · Sep 30, 2020 −$17.82M
Cash And Equivalents Q3 2021 · Sep 30, 2021 $93.23M
Cash And Equivalents Q3 2021 · Dec 31, 2020 $247.6M
Stockholders Equity Q3 2021 · Sep 30, 2021 $243.16M
Stockholders Equity Q3 2021 · Jun 30, 2021 $259.57M
Stockholders Equity Q3 2021 · Mar 31, 2021 $272.99M
Stockholders Equity Q3 2021 · Dec 31, 2020 $278.85M
Stockholders Equity Q3 2021 · Sep 30, 2020 $272.81M
Stockholders Equity Q3 2021 · Jun 30, 2020 $119.42M
Stockholders Equity Q3 2021 · Mar 31, 2020 $115.64M
Stockholders Equity Q3 2021 · Dec 31, 2019 −$1.33M
Current Liabilities Q3 2021 · Sep 30, 2021 $21.86M
Current Liabilities Q3 2021 · Dec 31, 2020 $21.42M
Total Liabilities Q3 2021 · Sep 30, 2021 $22.2M
Total Liabilities Q3 2021 · Dec 31, 2020 $21.98M
Current Assets Q3 2021 · Sep 30, 2021 $263.07M
Current Assets Q3 2021 · Dec 31, 2020 $298.53M
Total Assets Q3 2021 · Sep 30, 2021 $265.36M
Total Assets Q3 2021 · Dec 31, 2020 $300.82M
Sga Expense Q3 2021 · Sep 30, 2021 $9.53M
Sga Expense Q3 2021 · Sep 30, 2021 $19.59M
Sga Expense Q3 2021 · Sep 30, 2020 $5.52M
Sga Expense Q3 2021 · Sep 30, 2020 $33.89M
Rd Expense Q3 2021 · Sep 30, 2021 $9.93M
Rd Expense Q3 2021 · Sep 30, 2021 $29.85M
Rd Expense Q3 2021 · Sep 30, 2020 $7.48M
Rd Expense Q3 2021 · Sep 30, 2020 $19.64M
Net Income Q3 2021 · Sep 30, 2021 −$19.32M
Net Income Q3 2021 · Sep 30, 2021 −$48.58M
Net Income Q3 2021 · Jun 30, 2021 −$18.4M
Net Income Q3 2021 · Mar 31, 2021 −$10.86M
Net Income Q3 2021 · Sep 30, 2020 −$12.51M
Net Income Q3 2021 · Sep 30, 2020 −$52.02M
Net Income Q3 2021 · Jun 30, 2020 −$23.22M
Net Income Q3 2021 · Mar 31, 2020 −$16.3M
Operating Income Q3 2021 · Sep 30, 2021 −$19.45M
Operating Income Q3 2021 · Sep 30, 2021 −$49.43M
Operating Income Q3 2021 · Sep 30, 2020 −$12.99M
Operating Income Q3 2021 · Sep 30, 2020 −$53.41M
Revenue Q3 2021 · Sep 30, 2021 $10K
Revenue Q3 2021 · Sep 30, 2020 $115K